|

HS-20089 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

  • Hansoh BioMedical R&D Company3

Indications

  • Cancer3
  • Ovarian Cancer2
  • Fallopian Tube Cancer1
  • Primary Peritoneal Cancer1
  • Endometrial Cancer1

Other3 trials

HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors
Phase 1
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
Phase 3
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.